These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30001262)

  • 21. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention-Deficit/Hyperactivity Disorder Medication Use in Adolescents: The Patient's Perspective.
    Kosse RC; Bouvy ML; Philbert D; de Vries TW; Koster ES
    J Adolesc Health; 2017 Nov; 61(5):619-625. PubMed ID: 28899641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review of Factors Influencing the Three Phases of Medication Adherence in People with Attention-Deficit/Hyperactivity Disorder.
    Khan MU; Aslani P
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(6):398-418. PubMed ID: 31120328
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of a new scale to measure self-reported medication nonadherence.
    Unni EJ; Farris KB
    Res Social Adm Pharm; 2015; 11(3):e133-43. PubMed ID: 21272524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parent Perceptions of Their College Students' Self-Management of Attention-Deficit/Hyperactivity Disorder.
    Schaefer MR; Wagoner ST; Young ME; Kavookjian J; Shapiro SK; Gray WN
    J Adolesc Health; 2018 Nov; 63(5):636-642. PubMed ID: 30146437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
    Setyawan J; Guérin A; Hodgkins P; Gauthier G; Cloutier M; Wu E; Erder MH
    J Med Econ; 2013 Nov; 16(11):1275-89. PubMed ID: 24004347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examining why patients with attention-deficit/hyperactivity disorder lack adherence to medication over the long term: a review and analysis.
    Frank E; Ozon C; Nair V; Othee K
    J Clin Psychiatry; 2015 Nov; 76(11):e1459-68. PubMed ID: 26646041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment.
    Low AM; le Sommer J; Vangkilde S; Fagerlund B; Glenthøj B; Sonuga-Barke E; Habekost T; Jepsen JRM
    Int J Neuropsychopharmacol; 2018 Nov; 21(11):997-1006. PubMed ID: 30124878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis.
    Adler LA; Wilens T; Zhang S; Dittmann RW; D'Souza DN; Schuh L; Durell TM
    Clin Ther; 2012 Feb; 34(2):363-73. PubMed ID: 22285724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder.
    Martin CA; Guenthner G; Bingcang C; Rayens MK; Kelly TH
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):63-73. PubMed ID: 17343554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder?
    Sumner CR; Haynes VS; Teicher MH; Newcorn JH
    Postgrad Med; 2010 Sep; 122(5):52-61. PubMed ID: 20861588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
    Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
    Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents.
    Adler LA; Shaw DM; Spencer TJ; Newcorn JH; Hammerness P; Sitt DJ; Minerly C; Davidow JV; Faraone SV
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):238-44. PubMed ID: 22537184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The need for a paradigm shift in adherence research: The case of ADHD.
    Khan MU; Kohn M; Aslani P
    Res Social Adm Pharm; 2019 Mar; 15(3):318-320. PubMed ID: 29735387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing objective and self-reported measures of adherence in haemophilia.
    Guedes VG; Corrente JE; Farrugia A; Thomas S; Wachholz PA; de Oliveira Vidal EI
    Haemophilia; 2019 Sep; 25(5):821-830. PubMed ID: 31322311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic review.
    Caisley H; Müller U
    Eur Psychiatry; 2012 Jul; 27(5):343-9. PubMed ID: 22521805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.
    Sayner R; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Giangiacomo AL; Tudor G; Sleath B
    Clin Ther; 2015 Sep; 37(9):1975-85. PubMed ID: 26164785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.